Grünenthal Clinical Trial Portal
As a research-based pharmaceutical company, Grünenthal recognizes the importance of publicly registering clinical trials and making information including results available. Please consult the table below to easily find information on Grünenthal sponsored clinical trials.
Please read the important information below before accessing the Grünenthal Clinical Trial Portal.
Disclaimer
The portal does not propose to offer you therapeutic assistance or therapeutic suggestions, nor should this keep you from seeking your doctor´s advice before making any decisions on your treatment.
Healthcare professionals should not view this portal as a prescription consultation service. Please rather refer to the official prescription information which is approved and available in your country.
This portal was compiled with the utmost care. However, information given in the portal may differ with data published elsewhere. This may, for example, occur due to the scope and/or format of this portal. In case of doubt, please refer to the prescription information which is approved in your country.
Grünenthal cannot guarantee that the registries and databases referred to in the portal are properly maintained and disclaims any liability for information collected from such registries and databases.
Please note that our General Terms and Conditions as well as our Privacy Statement do also apply on the Grünenthal Clinical Trial Portal.
You can search for dedicated content in the portal by entering information in the filtering fields below.
Trial phase filter | Trial status filter | Results filter |
Trial ID | Compound | Indication | Brief title | Trial phase | Trial status | Results |
|---|---|---|---|---|---|---|
| Capsaicin 8% | Painful Diabetic Peripheral Neuropathy | Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy | 4 | Active, not recruiting | No | |
| Tegacorat (GRM-01) | Duchenne Muscular Dystrophy | Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019 | 1 | Active, not recruiting | No | |
| Tegacorat (GRM-01) | Duchenne Muscular Dystrophy | A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants | 1 | Active, not recruiting | No | |
| Nav1,8 | Acute & Chronic Pain | A First-in-human Trial of GRT7041 in Healthy Participants | 1 | Active, not recruiting | No | |
| Capsaicin 8% | Neuropathic pain | Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery (RISE) | 3 | Completed | No | |
| Axomadol | Chronic Low Back Pain | Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain | 2b | Completed | No | |
| Tramadol | Children undergoing elective limb surgery or urogenital surgery | Serum concentrations of tramadol and its metabolite Ml in children after intravenous or caudal extradural administration of tramadol-HCL | 3 | Completed | Yes | |
| Cebranopadol | Pharmacokinetic | A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol | 1 | Completed | No | |
| Axomadol | A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the Body | 1 | Completed | No | ||
| Axomadol | Pain, Acute Pain, Chronic Pain | A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally Tolerated | 1 | Completed | No |